Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Neurobiol Dis ; 45(1): 288-96, 2012 Jan.
Article de Anglais | MEDLINE | ID: mdl-21884793

RÉSUMÉ

We recently demonstrated that recombinant adeno-associated viral vector-induced hippocampal overexpression of neuropeptide Y receptor, Y2, exerts a seizure-suppressant effect in kindling and kainate-induced models of epilepsy in rats. Interestingly, additional overexpression of neuropeptide Y in the hippocampus strengthened the seizure-suppressant effect of transgene Y2 receptors. Here we show for the first time that another neuropeptide Y receptor, Y5, can also be overexpressed in the hippocampus. However, unlike Y2 receptor overexpression, transgene Y5 receptors in the hippocampus had no effect on kainate-induced motor seizures in rats. However, combined overexpression of Y5 receptors and neuropeptide Y exerted prominent suppression of seizures. This seizure-suppressant effect of combination gene therapy with Y5 receptors and neuropeptide Y was significantly stronger as compared to neuropeptide Y overexpression alone. These results suggest that overexpression of Y5 receptors in combination with neuropeptide Y could be an alternative approach for more effective suppression of hippocampal seizures.


Sujet(s)
Hippocampe/métabolisme , Embrasement/génétique , Neuropeptide Y/génétique , Récepteur neuropeptide Y/génétique , Crises épileptiques/génétique , Animaux , Acide kaïnique , Embrasement/métabolisme , Mâle , Neurones/métabolisme , Neuropeptide Y/métabolisme , Rats , Rats transgéniques , Rat Wistar , Récepteur neuropeptide Y/métabolisme , Crises épileptiques/induit chimiquement , Crises épileptiques/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...